Yong Han

461 total citations
24 papers, 317 citations indexed

About

Yong Han is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Yong Han has authored 24 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Yong Han's work include Renal Transplantation Outcomes and Treatments (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Fibroblast Growth Factor Research (2 papers). Yong Han is often cited by papers focused on Renal Transplantation Outcomes and Treatments (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Fibroblast Growth Factor Research (2 papers). Yong Han collaborates with scholars based in China, United States and United Kingdom. Yong Han's co-authors include Zhiyuan Zhang, Shuyang Sun, Shengming Xu, Rong Zhou, Guizhu Yang, Chaoji Shi, Xiaojuan Huang, Zhiyuan Zhang, Rujia Zou and Guoyu Zhou and has published in prestigious journals such as Clinical Cancer Research, British Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Yong Han

23 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yong Han China 10 145 123 68 54 49 24 317
Hongqian Guo China 10 170 1.2× 52 0.4× 34 0.5× 70 1.3× 45 0.9× 28 331
Siawosh K. Eskandari United States 8 156 1.1× 84 0.7× 115 1.7× 36 0.7× 54 1.1× 18 319
Mehmet Haluk Morgül Germany 10 72 0.5× 56 0.5× 28 0.4× 39 0.7× 59 1.2× 27 372
Xile Zhou China 7 193 1.3× 212 1.7× 163 2.4× 76 1.4× 32 0.7× 21 424
Zhenzhai Cai China 12 110 0.8× 84 0.7× 47 0.7× 40 0.7× 64 1.3× 26 293
Wu‐tong Ju China 11 128 0.9× 147 1.2× 50 0.7× 55 1.0× 44 0.9× 27 358
Shan Shao China 15 152 1.0× 55 0.4× 34 0.5× 49 0.9× 22 0.4× 37 443
Grace Cui United States 11 109 0.8× 47 0.4× 42 0.6× 31 0.6× 85 1.7× 17 281
Naifu Liu China 12 118 0.8× 85 0.7× 56 0.8× 81 1.5× 35 0.7× 31 374
Qin Han China 8 114 0.8× 72 0.6× 80 1.2× 58 1.1× 48 1.0× 19 312

Countries citing papers authored by Yong Han

Since Specialization
Citations

This map shows the geographic impact of Yong Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Han more than expected).

Fields of papers citing papers by Yong Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Han. The network helps show where Yong Han may publish in the future.

Co-authorship network of co-authors of Yong Han

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Han. A scholar is included among the top collaborators of Yong Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Han. Yong Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Keyong, Shengming Xu, Guanglong Liu, et al.. (2024). Porphyromonas gingivalis Promotes Oral Squamous Cell Carcinoma Progression by Modulating Autophagy. Oral Diseases. 31(2). 492–502. 4 indexed citations
2.
Xu, Huiyu, Wei Wang, Yong Han, Rong Li, & Jie Qiao. (2024). OvaRePred: Redefing ovarian aging and pioneering the journey towards women's health management. 2(2). 100068–100068. 3 indexed citations
3.
Zhou, Rong, et al.. (2023). Fibroblast growth factor receptors 1 and 4 combined with lymph node metastasis predicts poor prognosis in oral cancer. Oral Diseases. 30(3). 1004–1017. 2 indexed citations
4.
Liu, Shuli, Lin Zhang, Weimin Ye, et al.. (2023). Apatinib potentiates the therapeutic effect of anti‐PD‐1 in locally advanced head and neck cancers. Oral Diseases. 30(5). 2940–2951. 4 indexed citations
5.
Shi, Chaoji, Shengming Xu, Houyu Ju, et al.. (2022). Candidate therapeutic agents in a newly established triple wild‐type mucosal melanoma cell line. Cancer Communications. 42(7). 627–647. 7 indexed citations
6.
Xu, Shengming, Chaoji Shi, Ronghui Xia, et al.. (2022). Analysis of Immunological Characteristics and Genomic Alterations in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Based on PD-L1 Expression. Frontiers in Immunology. 12. 798424–798424. 9 indexed citations
7.
Han, Yong, Shengming Xu, Weimin Ye, et al.. (2021). Targeting LSD1 suppresses stem cell-like properties and sensitizes head and neck squamous cell carcinoma to PD-1 blockade. Cell Death and Disease. 12(11). 993–993. 34 indexed citations
8.
Wang, Yang, Yong Han, Shengming Xu, et al.. (2020). <p>Targeting EGFR Enriches Stem Cell-Like Properties in Salivary Adenoid Cystic Carcinoma by Activating the Notch1 Pathway</p>. Cancer Management and Research. Volume 12. 6655–6663. 5 indexed citations
9.
Fu, You, Yong Han, Ronghui Xia, et al.. (2020). Fewer tumour-specific PD-1+CD8+ TILs in high-risk “Infiltrating” HPV− HNSCC. British Journal of Cancer. 123(6). 932–941. 10 indexed citations
10.
Zhou, Rong, Chaoji Shi, Jiang Li, et al.. (2019). Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic Aberrations. Clinical Cancer Research. 25(12). 3548–3560. 64 indexed citations
11.
Xu, Shengming, Bao Sun, Rong Zhou, et al.. (2019). Evaluation of p16 as a surrogate marker for transcriptionally active human papillomavirus status of oropharyngeal squamous cell carcinoma in an eastern Chinese population. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 129(3). 236–245.e2. 10 indexed citations
12.
Han, Yong, Jing Wu, Xiaojuan Huang, et al.. (2019). Repurposing Ponatinib as a Potent Agent against KIT Mutant Melanomas. Theranostics. 9(7). 1952–1964. 17 indexed citations
13.
Sun, Shuyang, Yilong Wang, Rong Zhou, et al.. (2017). Targeting and Regulating of an Oncogene via Nanovector Delivery of MicroRNA using Patient-Derived Xenografts. Theranostics. 7(3). 677–693. 34 indexed citations
14.
Han, Yong, et al.. (2015). Renal graft biopsy assists diagnosis and treatment of renal allograft dysfunction after kidney transplantation: a report of 106 cases.. PubMed. 8(3). 4703–7. 3 indexed citations
15.
Han, Yong, Qiang Wang, Ming Cai, et al.. (2015). Characterisation of Tertiary Lymphoid Organs in Explanted Rejected Donor Kidneys. Immunological Investigations. 45(1). 38–51. 14 indexed citations
16.
Huang, Haiyan, Ming Cai, Yong Han, et al.. (2012). Combination of IL-1 Receptor Antagonist, IL-20 and CD40 Ligand for the Prediction of Acute Cellular Renal Allograft Rejection. Journal of Clinical Immunology. 33(1). 280–287. 14 indexed citations
17.
Kang, Yanjun, et al.. (2012). Analysis on Causes of a Well Casing Coupling Crack. Materials performance. 51(4). 58–62.
18.
Han, Yong, Hui Guo, Yanjie Xu, et al.. (2011). Pathological findings and clinical analyses on delayed renal graft function. Scientific Research and Essays. 6(22). 4744–4748. 1 indexed citations
19.
Han, Yong, Jian Wang, Wenhai Li, et al.. (2009). Non-thoracoscopic extrapleural Nuss procedure for the correction of pectus excavatum in children. European Journal of Cardio-Thoracic Surgery. 37(2). 312–5. 8 indexed citations
20.
Han, Yong, Qiang Lu, Tao Zhang, & Xiaoping Wang. (2008). Pneumopericardium and esophagopericardial fistula presenting as pericarditis in a 1-year-old boy. European Journal of Cardio-Thoracic Surgery. 34(5). 1120–1122. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026